The role of toll-like receptors in chronic B-cell malignancies (Q37578343)

21 August 2017

1 reference

title

The role of toll-like receptors in chronic B-cell malignancies (English)

1 reference

21 August 2017

0 references

Giorgia Simonetti

3

0 references

Marta Muzio

object named as

Marta Muzio

1

0 references

author name string

Maria T S Bertilaccio

2

1 reference

21 August 2017

Michela Frenquelli

4

1 reference

21 August 2017

Federico Caligaris-Cappio

5

1 reference

21 August 2017

publication date

1 October 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

50

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

1573-1580

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

21 August 2017

1 reference

Toll-like receptors: linking innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Toll-like receptors and innate immunity in B-cell activation and antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Toll-like receptors: lessons from knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Toll-like receptors (TLRs) signalling and expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

NOD-LRR proteins: role in host-microbial interactions and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Nod-like proteins in immunity, inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Toll-like receptor stimulation as a third signal required for activation of human naive B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

21 January 2018

TLR accessory molecules

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

B cell autonomous TLR signaling and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Maintenance of serological memory by polyclonal activation of human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

B cell antigen receptor signaling: roles in cell development and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

21 January 2018

Marginal-zone lymphoma.

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Inflammation and multiple myeloma: the Toll connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Toll-like receptors mediate proliferation and survival of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

The origin of B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Differential expression of CD180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Effect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4 , CD40L T cells by producing CCL22

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5 B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190903115410

10.1080/10428190903115410

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference